Adapthealth Corp. current report, 28 April 2021

AdaptHealth Corp. Form 8-K Summary

Business Context and Reporting Period

This Current Report on Form 8-K was filed by AdaptHealth Corp. on April 28, 2021. The filing addresses a material accounting error requiring the restatement of previously issued financial statements for the years ended December 31, 2020 and 2019, as well as interim periods in 2020.

Key Financial Metrics

The filing does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. Instead, it details a change in accounting classification:

  • Warrant Reclassification: Public and private warrants issued in 2017 are being reclassified from equity to liability under ASC Subtopic 815.
  • Impact on Operations: The change in fair value of the warrant liability is recognized as a non-cash charge or gain. The filing explicitly states this has no impact on reported net revenues, operating income, or cash flows from operating, investing, or financing activities.
  • Put/Call Option: A settlement amount from a Put/Call Option exercised in December 2020 will be restated as mezzanine equity for the period the agreement was outstanding.

Material Changes Versus Prior Period

The primary material change is the correction of accounting treatment for warrants following an April 12, 2021, SEC statement regarding special purpose acquisition company warrants. The company concluded that specific provisions in the Warrant Agreement (dated February 15, 2018) preclude equity classification because:

  • Settlement values could differ based on the holder.
  • The instrument is not "indexed to the Company's own stock."
  • Certain tender offers could result in cash settlement for warrant holders while common stockholders receive different treatment.

Consequently, the audited consolidated financial statements for 2019 and 2020, and unaudited interim statements for Q1, Q2, and Q3 2020, are no longer reliable in their original form.

Guidance, Outlook, and Risks

Management Commentary and Actions:

  • Management and the Audit Committee have concluded that restatements are necessary for all "Relevant Periods."
  • The company is filing a Form 10-K/A contemporaneously with this 8-K to include restated audited financials for 2019 and 2020.
  • Unaudited 2020 interim financial information will be revised in upcoming Form 10-Q filings.
  • Pro forma financial information related to the AeroCare Holdings, Inc. acquisition will be amended.
  • The warrant liability does not constitute indebtedness and will only be eliminated through exercise or expiration.

Risks and Contingencies:

  • Investors should not rely on previously issued financial statements for the periods mentioned above.
  • The company has discussed these matters with its independent auditor, KPMG LLP.

Important Facts for Investor Verification

  • Verify the restated financial figures in the accompanying Form 10-K/A for the years ended December 31, 2020 and 2019.
  • Monitor upcoming Form 10-Q filings for revised interim data for the first three quarters of 2020.
  • Confirm the updated pro forma financials regarding the AeroCare acquisition in the amended 8-K.
  • Note that while the warrant reclassification affects net income via non-cash charges/gains, it does not alter cash flow or revenue metrics.